| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,783,000 | 3,188,000 | 4,225,000 | 4,716,000 | | Cost of Revenue | 1,718,000 | 2,029,000 | 2,701,000 | 3,001,000 | | | Gross Profit | 1,065,000 | 1,159,000 | 1,524,000 | 1,715,000 | | | Operating Expenses | | Research Development | 94,000 | 107,000 | 114,000 | 119,000 | | Selling General and Administrative | 726,000 | 711,000 | 900,000 | 999,000 | | Non Recurring | 190,000 | 138,000 | 25,000 | 4,000 | | Others | 118,000 | 118,000 | 139,000 | 165,000 | | | | Total Operating Expenses | 1,128,000 | 1,074,000 | 1,178,000 | 1,287,000 | | | | Operating Income or Loss | (63,000) | 85,000 | 346,000 | 428,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 101,000 | (81,000) | 52,000 | | Earnings Before Interest And Taxes | (63,000) | 189,000 | 265,000 | 480,000 | | Interest Expense | 48,000 | 61,000 | 62,000 | 65,000 | | Income Before Tax | (111,000) | 128,000 | 203,000 | 415,000 | | Income Tax Expense | (20,000) | 46,000 | 65,000 | 124,000 | | Minority Interest |
-
| (11,000) | (21,000) | (28,000) | | | | Net Income From Continuing Ops | (91,000) | 71,000 | 117,000 | 263,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (13,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (91,000) | 71,000 | 117,000 | 250,000 | | Preferred Stock And Other Adjustments | (20,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($111,000) | $71,000 | $117,000 | $250,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
